Hummingbird Diagnostics
Hummingbird Diagnostics is an Heidelberg-based molecular diagnostics company developing liquid biopsy technology for early disease detection, personalized medicine, and lifetime monitoring of disease-specific biomarkers founded in 2017 by Ryan Gerard, Jesse Reiss, JoAnn Barefoot, Matthew Van Buskirk and Joe Robinson.
2
Funding Rounds
$14.2m
Money raised
Overview
Hummingbird Diagnostics is an Heidelberg-based molecular diagnostics company developing liquid biopsy technology for early disease detection, personalized medicine, and lifetime monitoring of disease-specific biomarkers founded in 2017 by Ryan Gerard, Jesse Reiss, JoAnn Barefoot, Matthew Van Buskirk and Joe Robinson.
-
Website:
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Jo*** Ba* | - | - | - |
| Jo* Ro* | - | - | - |
| Ma Va* Bu | - | - | - |
| Jo**** Ko* | - | - | |
| Ry** Ge**** | - | - | |
| Je*** Re*** |
|
- | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Jo* Ro* | - | - | - |
| Ma Va* Bu | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Hummingbird Diagnostics has raised a total of $11.21m in funding over 2 rounds.
Key Insights:
- Hummingbird Diagnostics Series A round, 2020: $8.2m
- Hummingbird Diagnostics Venture round, Oct 2018: $3.01m
Hummingbird Diagnostics Series A round, 2020
$8.2m
Hummingbird Diagnostics Venture round, Oct 2018
$3.01m
Industries
Hummingbird Diagnostics is active in the following industries: